Changes in plasma protein binding rate of remifentanil during cardiopulmonary bypass

Changes in plasma protein binding rate of remifentanil during cardiopulmonary bypass - Changes in plasma protein binding rate of remifentanil during cardiopulmonary bypass

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051469

Enrollment

Registered

2023-06-28

Start date

2017-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protein binding rate of remifentanil

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Undergoing heart or great vessel surgery using a heart-lung machine Use intraoperative remifentanil Gender does not matter 18 years of age or older ASA-PS (American Society of Anesthesiologists physical status) 1-3 Those who have been able to obtain consent for this research by signing a consent form by the person himself/herself or a proxy

Exclusion criteria

Exclusion criteria: Allergy to remifentanil Preoperative blood hemoglobin concentration of 7 g/dl or less Persons who could not obtain consent by signing a consent form by themselves or their legal representatives

Design outcomes

Primary

Measure	Time frame
protein binding rate of remifentanil	—

Countries

Japan

Contacts

Public ContactHiroshi Ueda

Hamamatsu University School of Medicine Department of Anesthesiology and Intensive Care

07484827@hama-med.ac.jp0534352738

Outcome results